Massachusetts-based biofuels technology firm Qteros appoints 16-year communications veteran Susan Hager as VP, corporate communications and government affairs

MARLBOROUGH, Massachusetts , April 26, 2010 (press release) – Qteros, Inc., a leading developer of next-generation technology solutions for the biofuels industry based on its unique Q Microbe™ platform, today announced the appointment of Susan Hager as Vice President of Corporate Communications and Government Affairs. In this role, Ms. Hager will report directly to John McCarthy, President and Chief Executive Officer. Jef Sharp, Senior Vice President of Corporate Communications and Government Affairs, Director and a member of the Qteros founding group, will continue to serve the Company as a member of Qteros' Board of Directors.

Ms. Hager will be responsible for leading all communications and government-related initiatives for the Company, with an emphasis on building and enhancing Qteros' unique positioning and brand within the industry. Ms. Hager's career spans more than 16 years, and has focused on developing results-driven communications campaigns for a broad portfolio of unique life science companies within both the private and public sectors. Her expertise includes corporate communications, investor relations, and media relations in support of complex product marketing and commercialization initiatives. Ms. Hager has considerable experience in advocacy relations and government affairs, specifically in developing and implementing communications programs to align influential advocacy groups and rally government support for various agency approvals and funding.

Prior to joining Qteros, Ms. Hager served as a Director in the Corporate Communications and Investor Relations practice for WCG, a leading global communications agency, where she created and led the implementation and execution of integrated, strategic communications programs for the firm's healthcare-focused clients in the United States and Europe. Ms. Hager has served previously as Vice President, Corporate Communications and Investor Relations for Targanta Therapeutics (sold to The Medicines Company), as well as Vice President, Corporate Communications, Investor Relations and Corporate Development for Coley Pharmaceutical Group (sold to Pfizer Inc). She has also held global marketing and communications roles with Bayer HealthCare LLC. Ms. Hager received a BS in Biology and an MBA from Northeastern University.

"We are delighted to welcome Sue to the team," said John McCarthy, President and CEO of Qteros. "In a time of significant progress and corporate growth at Qteros, Sue brings an essential combination of entrepreneurialism, high energy and deep experience developing corporate communications programs that advance sophisticated business objectives and drive shareholder value."

Mr. McCarthy continued, "As Sue assumes her new role spearheading Qteros' communications and government affairs initiatives, we are pleased that Jef Sharp will continue in his role as a member of Qteros' Board of Directors. Since co-founding the Company in 2006, Jef has made numerous contributions to Qteros' growth and advancement. I look forward to continued collaboration with him as the team works together to accelerate the commercial availability of advanced, low-cost biofuels from Qteros' unique consolidated bio-processing platform."

About Qteros, Inc.

Qteros is committed to delivering innovative process technologies for clean transportation fuels that reduce greenhouse gas emissions at a price competitive with gasoline. The Company is currently in the process of scaling up a unique microbial solution for the highly-efficient and cost-effective conversion of non-food biomass into clean transportation fuel. The Company's patented Q Microbe™ system converts a wide array of cellulosic biomass directly into ethanol in a single streamlined process, thereby consolidating enzymatic hydrolysis and fermentation, largely eliminating costly exogenous enzymes and associated pretreatments, and greatly simplifying the entire production process. This process is commonly referred to as consolidated bio-processing. Qteros' scientists and business team are dedicated to producing liquid fuels to achieve a sustainable solution to the world's growing energy needs. Qteros has been funded by some of the leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP Technology Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, visit

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.